Millennium Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Buy |
3,397,589
+2,527,880
| +291% | +$8.67M | 0.01% | 1505 |
|
|
2025
Q1 | $1.94M | Sell |
869,709
-613,006
| -41% | -$1.37M | ﹤0.01% | 2614 |
|
|
2024
Q4 | $4.34M | Buy |
1,482,715
+728,828
| +97% | +$2.14M | ﹤0.01% | 2086 |
|
|
2024
Q3 | $1.96M | Buy |
753,887
+303,197
| +67% | +$788K | ﹤0.01% | 2557 |
|
|
2024
Q2 | $1.33M | Sell |
450,690
-817,328
| -64% | -$2.42M | ﹤0.01% | 2711 |
|
|
2024
Q1 | $5.74M | Buy |
1,268,018
+12,799
| +1% | +$58K | ﹤0.01% | 1882 |
|
|
2023
Q4 | $7.17M | Sell |
1,255,219
-266,060
| -17% | -$1.52M | ﹤0.01% | 1676 |
|
|
2023
Q3 | $7M | Sell |
1,521,279
-1,746,339
| -53% | -$8.03M | ﹤0.01% | 1670 |
|
|
2023
Q2 | $21.1M | Buy |
3,267,618
+2,060,920
| +171% | +$13.3M | 0.01% | 949 |
|
|
2023
Q1 | $9.1M | Buy |
1,206,698
+779,150
| +182% | +$5.88M | 0.01% | 1505 |
|
|
2022
Q4 | $4.33M | Sell |
427,548
-441,756
| -51% | -$4.47M | ﹤0.01% | 2216 |
|
|
2022
Q3 | $8.6M | Sell |
869,304
-2,087,340
| -71% | -$20.6M | 0.01% | 1726 |
|
|
2022
Q2 | $31.5M | Buy |
2,956,644
+1,462,648
| +98% | +$15.6M | 0.02% | 605 |
|
|
2022
Q1 | $14.6M | Buy |
1,493,996
+797,635
| +115% | +$7.78M | 0.01% | 1234 |
|
|
2021
Q4 | $9.96M | Sell |
696,361
-151,458
| -18% | -$2.17M | 0.01% | 1589 |
|
|
2021
Q3 | $17M | Buy |
847,819
+782,162
| +1,191% | +$15.7M | 0.01% | 1019 |
|
|
2021
Q2 | $1.44M | Buy |
65,657
+41,269
| +169% | +$908K | ﹤0.01% | 3424 |
|
|
2021
Q1 | $828K | Sell |
24,388
-72,168
| -75% | -$2.45M | ﹤0.01% | 3360 |
|
|
2020
Q4 | $3.89M | Buy |
+96,556
| New | +$3.89M | ﹤0.01% | 2082 |
|